SEC Form 4 · accession 0001209191-15-048157
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Corinne H Nevinny
Director
Period of report
May 28, 2015
Accepted (ET)
Jun 1, 2015 · 6:22 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $42.76 | May 28, 2015 | A | 25,000 | A | Jun 28, 2015 | May 27, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Option vests in 12 equal monthly installments beginning June 28, 2015.